NanoViricides, Inc.
NYSE American:NNVC
Sector
Location
Market Cap
USD 25.39 M
Share Price
USD 1.58
Avg Daily Volume
258,566
Change (1 day)
0.00%
Change (1 year)
-16.84%
Change (YTD)
10.49%
NanoViricides, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending August 12, 2025: N/A
NanoViricides, Inc. EBITDA Margin is NA for the Trailing 12 Months (TTM) ending August 12, 2025. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
StockViz
Competitors
Applied DNA Sciences, Inc.
USD 4.27
APDN
+0.04
0.95%
Tempest Therapeutics, Inc.
USD 7.36
TPST
+0.33
4.69%
Indaptus Therapeutics, Inc.
USD 7.17
INDP
+0.43
6.33%
RenovoRx, Inc.
USD 1.14
RNXT
-0.06
-5.00%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|